Codexis (CDXS) Total Non-Current Liabilities (2010 - 2026)

Codexis (CDXS) recorded quarterly Total Non-Current Liabilities of $84.8 million in Q1 2026, down 11.61% quarter-over-quarter from $95.9 million in Q4 2025, and up 8.75% on a YoY basis from $78.0 million in Q1 2025.

Codexis (CDXS) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Codexis' Total Non-Current Liabilities history runs 17 years deep, the most recent figure standing at $84.8 million for Q1 2026.

  • In Q1 2026, Total Non-Current Liabilities rose 8.75% year-over-year to $84.8 million; the TTM figure through Mar 2026 stood at $84.8 million (up 8.75% YoY), while the FY2025 annual figure was $95.9 million, up 18.72% from the prior year.
  • Total Non-Current Liabilities was $84.8 million for Q1 2026 at Codexis, down from $95.9 million in the prior quarter.
  • In the past five years, Total Non-Current Liabilities ranged from a high of $104.2 million in Q4 2022 to a low of $48.7 million in Q4 2023.
  • Historically, Total Non-Current Liabilities has averaged $78.4 million across 5 years, with a median of $79.8 million in 2022.
  • The sharpest annual moves came in 2023 and 2024: Total Non-Current Liabilities plunged 53.26% in 2023, then jumped 65.9% in 2024.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $104.2 million in 2022, then slumped by 53.26% to $48.7 million in 2023, then surged by 65.9% to $80.8 million in 2024, then rose by 18.72% to $95.9 million in 2025, then retreated by 11.61% to $84.8 million in 2026.
  • The last three Total Non-Current Liabilities figures came in at $84.8 million (Q1 2026), $95.9 million (Q4 2025), and $84.1 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Alterity Therapeutics 719,706.53 Bn 719,706.50 Bn - 42,980.09
2 Belite Bio 55,800.00 Bn 55,800.00 Bn - -
3 Quantum Biopharma 18,182.30 Bn 18,182.29 Bn - 11.03 Mn
4 Legend Biotech 3,154.00 Bn 3,153.71 Bn 242.10 Mn 95.20 Mn
5 Akari Therapeutics 1,844.30 Bn 1,844.29 Bn - -
6 Evaxion A 1,567.96 Bn 1,567.94 Bn - -
7 Psyence Biomedical 251.43 Bn 251.42 Bn - 644,700.00
8 Vertex Pharmaceuticals 112.56 Bn 105.31 Bn 2.59 Bn 5.87 Bn
9 Abivax 94.37 Bn 94.37 Bn - 64.76 Mn
10 Codexis 236.00 Mn 170.86 Mn 13.18 Mn 84.80 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 84.80 Mn
Dec 31, 2025 95.94 Mn
Sep 30, 2025 84.11 Mn
Jun 30, 2025 81.32 Mn
Mar 31, 2025 77.98 Mn
Dec 31, 2024 80.82 Mn
Sep 30, 2024 73.50 Mn
Jun 30, 2024 69.30 Mn
Mar 31, 2024 69.04 Mn
Dec 31, 2023 48.71 Mn
Sep 30, 2023 61.73 Mn
Jun 30, 2023 81.23 Mn
Mar 31, 2023 90.66 Mn
Dec 31, 2022 104.23 Mn
Sep 30, 2022 79.80 Mn
Jun 30, 2022 74.17 Mn
Mar 31, 2022 75.31 Mn
Dec 31, 2021 80.68 Mn
Sep 30, 2021 57.45 Mn
Jun 30, 2021 48.25 Mn